Literature DB >> 15304001

The LILR family: modulators of innate and adaptive immune pathways in health and disease.

D Brown1, J Trowsdale, R Allen.   

Abstract

Leukocyte immunoglobulin (Ig)-like receptors [LILRs, also known as Ig-like transcripts (ILTs)] are a family of inhibitory and stimulatory receptors encoded within the leukocyte receptor complex and are expressed by immune cell types of both myeloid and lymphoid lineage. Several members of the LILR family recognize major histocompatibility complex class I. The immunomodulatory role of LILR receptors indicates that they may exert an influence on signaling pathways of both innate and adaptive immune systems. LILR activity can also influence the antigen-presenting properties of macrophages and dendritic cells and may thus play a role in T-cell tolerance. The wide-ranging effects of LILR signaling on immune cell activity imply that these receptors are likely to play an important role in a range of clinical situations including pregnancy, transplantation, and arthritis (including the human leukocyte antigen B27-associated spondyloarthropathies). In this review, we summarize current knowledge on the nature and function of LILRs, focusing on their regulation of immune cell activity and their potential role in disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304001     DOI: 10.1111/j.0001-2815.2004.00290.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  113 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 2.  Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?

Authors:  Huan Cao; Paul R Crocker
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

Review 3.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

4.  HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I.

Authors:  Joanna Giles; Jackie Shaw; Christopher Piper; Isabel Wong-Baeza; Kirsty McHugh; Anna Ridley; Demin Li; Izabela Lenart; Antony N Antoniou; Katilin DiGleria; Kimiko Kuroki; Katsumi Maenaka; Paul Bowness; Simon Kollnberger
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

Review 5.  Stranger in a strange land.

Authors:  Joan S Hunt
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 6.  Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritis.

Authors:  T R D J Radstake; A W T van Lieshout; P L C M van Riel; W B van den Berg; G J Adema
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

7.  A commentary on gestational programming and functions of HLA-G in pregnancy.

Authors:  J S Hunt; P J Morales; J L Pace; A T Fazleabas; D K Langat
Journal:  Placenta       Date:  2007-03-09       Impact factor: 3.481

Review 8.  Molecular characterization of human plasmacytoid dendritic cells.

Authors:  Wei Cao
Journal:  J Clin Immunol       Date:  2009-03-06       Impact factor: 8.317

9.  Microbially cleaved immunoglobulins are sensed by the innate immune receptor LILRA2.

Authors:  Kouyuki Hirayasu; Fumiji Saito; Tadahiro Suenaga; Kyoko Shida; Noriko Arase; Keita Oikawa; Toshifumi Yamaoka; Hiroyuki Murota; Hiroji Chibana; Ichiro Nakagawa; Tomoko Kubori; Hiroki Nagai; Yuji Nakamaru; Ichiro Katayama; Marco Colonna; Hisashi Arase
Journal:  Nat Microbiol       Date:  2016-04-25       Impact factor: 17.745

10.  Functional classification of immune regulatory proteins.

Authors:  Rotem Rubinstein; Udupi A Ramagopal; Stanley G Nathenson; Steven C Almo; Andras Fiser
Journal:  Structure       Date:  2013-04-11       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.